Diagnosticos Da America S.a.BMFBOVESPA: DASA3

EBITDA up 28% and net income positive, with leverage and free cash flow significantly improved

· Issued by Diagnosticos Da America S.A.

EBITDA rose 28% year-over-year (Current Scope) with margin expansion and improved efficiency, while net income turned positive at R$9 million. Leverage declined to 2.99x, and free cash flow improved by R$101 million, reflecting disciplined capital allocation and operational gains.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Diagnosticos Da America

All Diagnosticos Da America news releases